The study of ALS biomarker based on molecular dynamics of oxidative stress regulatory factor

Not Applicable

• Conditions: Amyotrophic lateral sclerosis Parkinson' s disease Multiple sclerosis Healthy individuals

• Registration Number: JPRN-UMIN000013245
• Lead Sponsor: Faculty of Medicine, Kitasato University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-02-25
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patient to whom the diagnosis has not been disclosed 2)Patient having severe psychiatric symptoms (hallucination, delusion) or dementia 3)Patient having serious orthostatic hypotension or other types of hypotension 4)Patient having a severe complication(s) such as heart, kidney and/or liver disease 5)Patient having the complications of the allergic disease that an acidophile level is easy to rise 6)Patient did not have ability to comprehend informed consent 7)Patient who was inappropriate for this study 8)Patient who has received an investigational drugs or devices within three months before 9) Patient who participates in other clinical trials *The patient treated with existing therapeutic drug does not correspond to exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Exploration of novel biomarker